NDC 0941-0413

DIANEAL PD-2 with Dextrose

Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose

DIANEAL PD-2 with Dextrose is a Intraperitoneal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Calcium Chloride; Dextrose Monohydrate; Magnesium Chloride; Sodium Chloride; Sodium Lactate.

Product ID0941-0413_1bac9069-af32-4e88-9d96-bf4006f0729f
NDC0941-0413
Product TypeHuman Prescription Drug
Proprietary NameDIANEAL PD-2 with Dextrose
Generic NameSodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose
Dosage FormInjection, Solution
Route of AdministrationINTRAPERITONEAL
Marketing Start Date1978-09-27
Marketing CategoryNDA / NDA
Application NumberNDA017512
Labeler NameBaxter Healthcare Corporation
Substance NameCALCIUM CHLORIDE; DEXTROSE MONOHYDRATE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
Active Ingredient Strength26 mg/100mL; g/100mL; mg/100mL; mg/100mL; mg/100mL
Pharm ClassesBlood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0941-0413-01

6000 mL in 1 BAG (0941-0413-01)
Marketing Start Date1978-09-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0941-0413-28 [00941041328]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27
Marketing End Date2013-02-28

NDC 0941-0413-06 [00941041306]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27

NDC 0941-0413-45 [00941041345]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2003-02-28

NDC 0941-0413-42 [00941041342]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2003-11-30

NDC 0941-0413-47 [00941041347]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27
Marketing End Date2013-03-31

NDC 0941-0413-08 [00941041308]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2015-02-18

NDC 0941-0413-48 [00941041348]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2009-12-31

NDC 0941-0413-07 [00941041307]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27

NDC 0941-0413-04 [00941041304]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27

NDC 0941-0413-49 [00941041349]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27
Marketing End Date2012-09-30

NDC 0941-0413-44 [00941041344]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2002-02-28

NDC 0941-0413-05 [00941041305]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27

NDC 0941-0413-25 [00941041325]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27
Marketing End Date2013-05-31

NDC 0941-0413-01 [00941041301]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27

NDC 0941-0413-40 [00941041340]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2002-07-31

NDC 0941-0413-41 [00941041341]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1978-09-27
Marketing End Date2002-07-31

NDC 0941-0413-43 [00941041343]

DIANEAL PD-2 with Dextrose INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA017512
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1978-09-27
Marketing End Date2012-02-29

Drug Details

Active Ingredients

IngredientStrength
DEXTROSE MONOHYDRATE2.5 g/100mL

OpenFDA Data

SPL SET ID:aa268d3f-7389-4f25-801f-5d4825495f08
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 800472
  • 800057
  • 800064
  • 800066
  • 800061
  • 800062
  • 800074
  • 799999
  • 800111
  • 800474
  • 800003
  • 800115
  • Pharmacological Class

    • Blood Coagulation Factor [EPC]
    • Increased Coagulation Factor Activity [PE]
    • Calcium [CS]
    • Cations
    • Divalent [CS]
    • Calculi Dissolution Agent [EPC]
    • Magnesium Ion Exchange Activity [MoA]
    • Osmotic Laxative [EPC]
    • Osmotic Activity [MoA]
    • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]
    • Increased Large Intestinal Motility [PE]
    • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]
    • Osmotic Laxative [EPC]
    • Increased Large Intestinal Motility [PE]
    • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
    • Osmotic Activity [MoA]

    NDC Crossover Matching brand name "DIANEAL PD-2 with Dextrose" or generic name "Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose"

    NDCBrand NameGeneric Name
    0941-0411DIANEAL PD-2 with Dextrosesodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
    0941-0413DIANEAL PD-2 with Dextrosesodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
    0941-0415DIANEAL PD-2 with Dextrosesodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
    0941-0429DIANEAL PD-2 with DextroseDIANEAL PD-2 with Dextrose
    0941-0427DIANEAL PD-2 with DextroseDIANEAL PD-2 with Dextrose
    0941-0426DIANEAL PD-2 with DextroseDIANEAL PD-2 with Dextrose
    0941-0409DIANEAL Low Calcium with Dextrosesodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
    0941-0424DIANEAL Low Calcium with Dextrosesodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.